182 related articles for article (PubMed ID: 20719221)
1. Human papillomavirus vaccine safety in Australia: experience to date and issues for surveillance.
Gold MS; McIntyre P
Sex Health; 2010 Sep; 7(3):320-4. PubMed ID: 20719221
[TBL] [Abstract][Full Text] [Related]
2. Low rates of free human papillomavirus vaccine uptake among young women.
Moore GR; Crosby RA; Young A; Charnigo R
Sex Health; 2010 Sep; 7(3):287-90. PubMed ID: 20719216
[TBL] [Abstract][Full Text] [Related]
3. National survey of general practitioners' experience of delivering the National Human Papillomavirus Vaccination Program.
Brotherton JM; Leask J; Jackson C; McCaffery K; Trevena LJ
Sex Health; 2010 Sep; 7(3):291-8. PubMed ID: 20719217
[TBL] [Abstract][Full Text] [Related]
4. Knowledge of human papillomavirus (HPV) and the HPV vaccine in a national sample of Australian men and women.
Pitts MK; Heywood W; Ryall R; Smith AM; Shelley JM; Richters J; Simpson JM
Sex Health; 2010 Sep; 7(3):299-303. PubMed ID: 20719218
[TBL] [Abstract][Full Text] [Related]
5. Quadrivalent HPV vaccination reactions--more hype than harm.
Douglas RJ
Aust Fam Physician; 2009 Mar; 38(3):139-42. PubMed ID: 19283255
[TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus vaccines: an update for gynecologists.
Ault KA
Clin Obstet Gynecol; 2008 Sep; 51(3):527-32. PubMed ID: 18677145
[TBL] [Abstract][Full Text] [Related]
7. Role of the nurse immuniser in implementing and maintaining the National Human Papillomavirus 'Cervical Cancer' Vaccine rollout through a school-based program in Victoria.
Kent H; Heffernan ME; Silvers J; Moore E; Garland SM
Sex Health; 2010 Sep; 7(3):391-3. PubMed ID: 20719232
[TBL] [Abstract][Full Text] [Related]
8. Global reduction of cervical cancer with human papillomavirus vaccines: insights from the hepatitis B virus vaccine experience.
Heffernan ME; Garland SM; Kane MA
Sex Health; 2010 Sep; 7(3):383-90. PubMed ID: 20719231
[TBL] [Abstract][Full Text] [Related]
9. A brief history of economic evaluation for human papillomavirus vaccination policy.
Beutels P; Jit M
Sex Health; 2010 Sep; 7(3):352-8. PubMed ID: 20719227
[TBL] [Abstract][Full Text] [Related]
10. 'It's a logistical nightmare!' Recommendations for optimising human papillomavirus school-based vaccination experience.
Robbins SC; Bernard D; McCaffery K; Skinner SR
Sex Health; 2010 Sep; 7(3):271-8. PubMed ID: 20719214
[TBL] [Abstract][Full Text] [Related]
11. What can surveillance of genital warts tell us?
Fairley CK; Donovan B
Sex Health; 2010 Sep; 7(3):325-7. PubMed ID: 20719222
[TBL] [Abstract][Full Text] [Related]
12. Models of cervical screening in the era of human papillomavirus vaccination.
Canfell K
Sex Health; 2010 Sep; 7(3):359-67. PubMed ID: 20719228
[TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus (HPV) vaccine acceptance and perceived effectiveness, and HPV infection concern among young New Zealand university students.
Chelimo C; Wouldes TA; Cameron LD
Sex Health; 2010 Sep; 7(3):394-6. PubMed ID: 20719233
[TBL] [Abstract][Full Text] [Related]
14. Clinical trial and post-licensure safety profile of a prophylactic human papillomavirus (types 6, 11, 16, and 18) l1 virus-like particle vaccine.
Block SL; Brown DR; Chatterjee A; Gold MA; Sings HL; Meibohm A; Dana A; Haupt RM; Barr E; Tamms GM; Zhou H; Reisinger KS
Pediatr Infect Dis J; 2010 Feb; 29(2):95-101. PubMed ID: 19952863
[TBL] [Abstract][Full Text] [Related]
15. [Vaccination against human papillomaviridae. Expert correspondence no. 18 of 29 December 2006].
Kommission Qualitätssicherung der Schweizerischen Gesellschaft für Gynäkologie und Geburtshilfe
Gynakol Geburtshilfliche Rundsch; 2007; 47(2):101-2. PubMed ID: 17440273
[No Abstract] [Full Text] [Related]
16. Human papillomavirus vaccine acceptability among young adult men.
Gerend MA; Barley J
Sex Transm Dis; 2009 Jan; 36(1):58-62. PubMed ID: 18830138
[TBL] [Abstract][Full Text] [Related]
17. Challenges, lessons learned and results following the implementation of a human papilloma virus school vaccination program in South Australia.
Watson M; Shaw D; Molchanoff L; McInnes C
Aust N Z J Public Health; 2009 Aug; 33(4):365-70. PubMed ID: 19689598
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus vaccine: recommendations, issues and controversies.
Fisher R; Darrow DH; Tranter M; Williams JV
Curr Opin Pediatr; 2008 Aug; 20(4):441-5. PubMed ID: 18622201
[TBL] [Abstract][Full Text] [Related]
19. Guillain-Barré syndrome after Gardasil vaccination: data from Vaccine Adverse Event Reporting System 2006-2009.
Souayah N; Michas-Martin PA; Nasar A; Krivitskaya N; Yacoub HA; Khan H; Qureshi AI
Vaccine; 2011 Jan; 29(5):886-9. PubMed ID: 20869467
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus (HPV) vaccines: a Canadian update.
Foerster V; Murtagh J
Issues Emerg Health Technol; 2007 Dec; (109):1-8. PubMed ID: 18062141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
